L-METHYLFOLATE TREATMENT FOR PSYCHIATRIC OR NEUROLOGIC DISORDERS
    85.
    发明公开
    L-METHYLFOLATE TREATMENT FOR PSYCHIATRIC OR NEUROLOGIC DISORDERS 审中-公开
    L-甲基治疗精神病学或神经系统疾病

    公开(公告)号:EP2588146A1

    公开(公告)日:2013-05-08

    申请号:EP11801314.3

    申请日:2011-06-09

    IPC分类号: A61K51/00 A61M36/14

    CPC分类号: A61K31/519

    摘要: Provided herein are methods of treating neuropsychiatric disorders or improving the symptoms associated therewith administering a medical food, such as L-methylfolate, to a subject having the disorder. The neuropsychiatric disorder may be an autism spectrum disorder or attention deficit disorder with or without hyperactivity (ADD/ADHD). The L-methylfolate may be administered as an adjunct to other therapeutic agents effective to treat the disorder. The subject preferably may be a child and also may have a single nucleotide polymorphism in the
    MTHFR gene associated with reduced expression of MTHFR enzyme. Also provided is a method of increasing the de novo synthesis of neurotransmitters in vivo by transporting a methyl-donating compound across the blood-brain barrier in a subject.